Relay Therapeutics, Inc.
RLAY
$3.69
$0.288.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -23.26% | 100.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -23.26% | 100.00% | -- | -- |
| Cost of Revenue | -33.18% | -10.43% | -12.78% | -5.98% | 4.30% |
| Gross Profit | 33.91% | 8.66% | 12.78% | -36.11% | -4.44% |
| SG&A Expenses | -31.71% | -5.35% | 0.76% | 6.84% | 0.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.91% | -9.45% | -9.85% | -3.61% | 3.52% |
| Operating Income | 33.52% | 7.95% | 9.85% | -28.88% | -3.63% |
| Income Before Tax | 23.68% | 5.31% | 8.97% | -34.03% | 6.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.68% | 5.31% | 8.97% | -34.03% | 6.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.68% | 5.31% | 8.97% | -34.03% | 6.39% |
| EBIT | 33.52% | 7.95% | 9.85% | -28.88% | -3.63% |
| EBITDA | 33.60% | 7.86% | 9.95% | -29.41% | -3.64% |
| EPS Basic | 40.82% | 26.78% | 32.14% | -16.83% | 14.23% |
| Normalized Basic EPS | 49.04% | 28.40% | 33.78% | -14.72% | 5.73% |
| EPS Diluted | 40.82% | 26.78% | 32.14% | -16.83% | 14.23% |
| Normalized Diluted EPS | 49.04% | 28.40% | 33.78% | -14.72% | 5.73% |
| Average Basic Shares Outstanding | 28.94% | 29.34% | 34.14% | 14.72% | 9.16% |
| Average Diluted Shares Outstanding | 28.94% | 29.34% | 34.14% | 14.72% | 9.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |